Question 1

Does Natixis own QNCX stock?

Accepted Answer

No. Natixis exited its QNCX (Quince Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 6,114 shares worth $306,000.

Question 2

How many shares of QNCX does Natixis own?

Accepted Answer

None since Q4 2020, when Natixis exited the position. Its Q3 2020 13F listed 6,114 shares worth $306,000.

Question 3

What is Natixis' QNCX position worth?

Accepted Answer

Natixis' QNCX position was worth $306,000 in its Q3 2020 13F, before the exit in Q4 2020.

Question 4

Is Natixis buying or selling QNCX?

Accepted Answer

In Q4 2020, Natixis exited its entire QNCX position.

Question 5

When did Natixis first buy QNCX?

Accepted Answer

Natixis first reported QNCX in its Q3 2019 13F and listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2020-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$5,556.00	0
2020-Q3	Decreased	6,114	-49.8%	$306,000	0.0%	$10,000.00	0
2020-Q2	Decreased	12,181	-26.6%	$564,000	0.0%	$9,260.00	0
2020-Q1	Increased	16,595	+38.2%	$757,000	0.0%	$9,122.00	32
2019-Q4	Decreased	12,011	-5.0%	$674,000	0.0%	$11,228.00	0
2019-Q3	New	12,645	-	$315,000	0.0%	$4,986.00	33